Prostate cancer and microRNAs: New insights into apoptosis

Prostate cancer (PCa) is known as one of the most prevalent malignancies globally and is not yet curable owing to its progressive nature. It has been well documented that Genetic and epigenetic alterations maintain mandatory roles in PCa development. Apoptosis, a form of programmed cell death, has b...

Full description

Saved in:
Bibliographic Details
Published in:Pathology, research and practice research and practice, 2023-05, Vol.245, p.154436-154436, Article 154436
Main Authors: Gupta, Jitendra, Abdulsahib, Waleed K., Turki Jalil, Abduladheem, Saadi Kareem, Doaa, Aminov, Zafar, Alsaikhan, Fahad, Ramírez-Coronel, Andrés Alexis, Ramaiah, Pushpamala, Farhood, Bagher
Format: Article
Language:English
Subjects:
Apoptosis - genetics
Apoptosis pathways
Cell Proliferation
Gene Expression Regulation, Neoplastic - genetics
Humans
Male
MicroRNA
MicroRNAs - genetics
MicroRNAs - metabolism
Non-coding RNAs
Oncogenes
Prostate cancer
Prostatic Neoplasms - pathology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Prostate cancer (PCa) is known as one of the most prevalent malignancies globally and is not yet curable owing to its progressive nature. It has been well documented that Genetic and epigenetic alterations maintain mandatory roles in PCa development. Apoptosis, a form of programmed cell death, has been shown to be involved in a number of physiological processes. Apoptosis disruption is considered as one of the main mechanism involved in lots of pathological conditions, especially malignancy. There is ample of evidence in support of the fact that microRNAs (miRNAs) have crucial roles in several cellular biological processes, including apoptosis. Escaping from apoptosis is a common event in malignancy progression. Emerging evidence revealed miRNAs capabilities to act as apoptotic or anti-apoptotic factors by altering the expression levels of tumor inhibitor or oncogene genes. In the present narrative review, we described in detail how apoptosis dysfunction could be involved in PCa processes and additionally, the mechanisms behind miRNAs affect the apoptosis pathways in PCa. Identifying the mechanisms behind the effects of miRNAs and their targets on apoptosis can provide scientists new targets for PCa treatment.
ISSN:0344-0338
1618-0631
DOI:10.1016/j.prp.2023.154436